SPPL2A
Basic information
Region (hg38): 15:50702266-50765948
Links
Phenotypes
GenCC
Source:
- immunodeficiency 86 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 86 | AR | Allergy/Immunology/Infectious | The condition involves susceptibility to mycobacterial disease after BCG vaccine, and susbequent localized mycobacterial lymphadenopathy is amenable to treatment | Allergy/Immunology/Infectious | 23472171; 30127434 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPPL2A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 45 | 49 | ||||
missense | 144 | 155 | ||||
nonsense | 3 | |||||
start loss | 2 | |||||
frameshift | 6 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 15 | 11 | 6 | 32 | ||
non coding | 44 | 56 | ||||
Total | 0 | 0 | 166 | 96 | 14 |
Variants in SPPL2A
This is a list of pathogenic ClinVar variants found in the SPPL2A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-50707800-T-G | Uncertain significance (Dec 23, 2024) | |||
15-50707805-G-A | Uncertain significance (Sep 10, 2023) | |||
15-50707809-G-C | Benign (Jan 29, 2025) | |||
15-50707817-G-C | Uncertain significance (Nov 14, 2020) | |||
15-50707828-A-G | not specified | Likely benign (Oct 29, 2024) | ||
15-50707846-T-C | Uncertain significance (Jun 23, 2022) | |||
15-50707853-C-T | Uncertain significance (Nov 28, 2023) | |||
15-50707880-C-A | Likely benign (Mar 11, 2022) | |||
15-50707893-C-A | Likely benign (Sep 03, 2024) | |||
15-50707894-G-A | Likely benign (Mar 04, 2024) | |||
15-50719921-C-T | Likely benign (Apr 03, 2021) | |||
15-50719927-T-C | Likely benign (Aug 27, 2023) | |||
15-50719939-C-A | Uncertain significance (Jan 16, 2022) | |||
15-50719944-T-C | not specified | Uncertain significance (Feb 14, 2025) | ||
15-50719948-T-C | not specified | Uncertain significance (Aug 09, 2024) | ||
15-50719955-T-C | Likely benign (Jan 28, 2025) | |||
15-50719969-T-G | Uncertain significance (Dec 04, 2024) | |||
15-50719980-C-T | not specified | Uncertain significance (Nov 20, 2023) | ||
15-50719981-G-A | Uncertain significance (Nov 28, 2023) | |||
15-50719990-C-T | Uncertain significance (Jul 04, 2024) | |||
15-50719997-T-C | Likely benign (Nov 27, 2023) | |||
15-50720004-G-C | Benign (Feb 03, 2025) | |||
15-50720007-A-G | Uncertain significance (Jan 23, 2025) | |||
15-50720013-G-C | Uncertain significance (Feb 14, 2024) | |||
15-50720018-A-T | Likely benign (Nov 04, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPPL2A | protein_coding | protein_coding | ENST00000261854 | 15 | 58500 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0290 | 0.971 | 125718 | 0 | 25 | 125743 | 0.0000994 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.929 | 219 | 261 | 0.838 | 0.0000122 | 3380 |
Missense in Polyphen | 56 | 77.808 | 0.71972 | 1022 | ||
Synonymous | 0.721 | 79 | 87.6 | 0.902 | 0.00000431 | 985 |
Loss of Function | 3.44 | 8 | 27.4 | 0.292 | 0.00000132 | 356 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000184 | 0.000182 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.000142 | 0.000139 |
European (Non-Finnish) | 0.000134 | 0.000132 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.0000353 | 0.0000327 |
Other | 0.000170 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Intramembrane-cleaving aspartic protease (I-CLiP) that cleaves type II membrane signal peptides in the hydrophobic plane of the membrane. Functions in FASLG, ITM2B and TNF processing (PubMed:16829952, PubMed:16829951, PubMed:17557115, PubMed:17965014). Catalyzes the intramembrane cleavage of the anchored fragment of shed TNF-alpha (TNF), which promotes the release of the intracellular domain (ICD) for signaling to the nucleus (PubMed:16829952). Also responsible for the intramembrane cleavage of Fas antigen ligand FASLG, which promotes the release of the intracellular FasL domain (FasL ICD) (PubMed:17557115). May play a role in the regulation of innate and adaptive immunity (PubMed:16829952). Catalyzes the intramembrane cleavage of the simian foamy virus envelope glycoprotein gp130 independently of prior ectodomain shedding by furin or furin-like proprotein convertase (PC)-mediated cleavage proteolysis (PubMed:23132852). {ECO:0000269|PubMed:16829951, ECO:0000269|PubMed:16829952, ECO:0000269|PubMed:17557115, ECO:0000269|PubMed:17965014, ECO:0000269|PubMed:23132852}.;
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.633
- rvis_EVS
- 0.97
- rvis_percentile_EVS
- 90.34
Haploinsufficiency Scores
- pHI
- 0.512
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sppl2a
- Phenotype
- cellular phenotype; hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- membrane protein ectodomain proteolysis;regulation of tumor necrosis factor-mediated signaling pathway;membrane protein intracellular domain proteolysis;membrane protein proteolysis;regulation of immune response
- Cellular component
- lysosomal membrane;late endosome;plasma membrane;membrane;Golgi-associated vesicle membrane;late endosome membrane;intracellular membrane-bounded organelle;extracellular exosome;integral component of cytoplasmic side of endoplasmic reticulum membrane;integral component of lumenal side of endoplasmic reticulum membrane
- Molecular function
- protein binding;aspartic endopeptidase activity, intramembrane cleaving;protein homodimerization activity